Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New Novartis rival Kisqali hasn't slowed down Pfizer's Ibrance—at least not yet
New Novartis rival Kisqali hasn't slowed down Pfizer's Ibrance—at least not yet
New Novartis rival Kisqali hasn't slowed down Pfizer's Ibrance—at least not yet
Submitted by
admin
on August 7, 2017 - 1:32pm
Source:
Fierce Pharma
News Tags:
Novartis
Kisqali
Pfizer
Ibrance
breast cancer
Headline:
New Novartis rival Kisqali hasn't slowed down Pfizer's Ibrance—at least not yet
Do Not Allow Advertisers to Use My Personal information
